Donated medicines for neglected tropical diseases have improved the lives of billions of people. Together, we can ensure those still at risk are #NeglectedNoMore.

A Historic Public-Private Partnership

  • Since 2012, companies have donated more than 14 billion NTD treatments. As a result, more people than ever before receive at least one NTD drug: from 727 million in 2011 to more than 1.1 billion in 2019.

  • In 2019 alone, pharmaceutical companies donated nearly 1.8 billion NTD treatments compared to 970 million in treatments in 2011.

  • Since 2016, over 797 million individuals every year have received preventive chemotherapy (PC) interventions for at least one NTD.

  • Between 2010 and 2020, the number of people requiring treatment for at least one NTD fell from 2 billion to 1.7 billion, a drop of 300 million people.